glutathione mutations in sclc patients

glutathione mutations in sclc patients Inhibiting the system xC−/glutathione axis selectively targets cancers with mutant-p53 accumulation Differential KEAP1/NRF2 mediated signaling widens

Name: glutathione mutations in sclc patients Inhibiting the system xC−/glutathione axis selectively targets cancers with mutant-p53 accumulation Differential KEAP1/NRF2 mediated signaling widens
Brand: webdevsolutions.tech
SKU: 27029319619
Price: 26.89 USD
Availability: InStock
Rating: 4.7434 (27 reviews)

Differential KEAP1 NRF2 mediated signaling widens the therapeutic window of redox targeting drugs in SCLC therapy Nature Communications In vivo functional screens reveal KEAP1 loss as a driver of chemoresistance in small cell lung cancer Science Advances Small cells big issues: biological implications and preclinical advancements in small cell lung cancer Molecular Cancer Springer Nature Link Oncology Letters

SKU: 27029319619 · From webdevsolutions.tech

4.7

USD26.89 USD66.89

Pay in 4 interest-free payments of $6.72 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 19 - Aug 24

Description

The ameliorative effect of N-acetylcysteine against penconazole induced neurodegenerative and neuroinflammatory disorders in rats

For sensitive skin, the Beauty Time team recommends starting with once daily use and then gradually increasing use to avoid any irritation

For each study whose data was summarized in tables, we provided the dose or concentration levels, duration of exposure and, if appropriate, the day or time after the initiation of dosing when the parameter listed in the table were assessed